BACKGROUND: Smoking in renal transplant recipients (RTR) is an acknowledged cardiovascular risk factor. It is, however, unclear whether smoking also increases the risk of graft failure (GF). METHOD: In this study, we prospectively assessed the association of current smoking versus past and never smoking with GF and mortality in 604 RTR (age 51.5 ± 12.1 years, 55% male). RESULTS: At inclusion, 133 (22%) were current smokers, 255 (42%) were past smokers and 216 (36%) never smoked. During follow-up of 5.3 (4.7-5.7) years, 41 (7%) RTR experienced GF and 95 RTR (16%) died. Current smoking RTR had higher risk for GF compared to never smoking RTR (hazard ratio, HR = 3.3, 95% CI 1.5-7.1, p = 0.002). Past smoking RTR had similar risk of GF as never smoking RTR (HR = 1.1, 95% CI 0.5-2.6, p = 0.7). Current smoking RTR and past smoking RTR were at higher risk for death than never smoking RTR (HR = 2.1, 95% CI 1.1-3.8, p = 0.016, and HR = 2.4, 95% CI 1.4-4.0, p = 0.001, respectively). CONCLUSION: Smoking after renal transplantation is associated with risk for GF and mortality. Since past smoking is a risk factor for mortality but not for GF, smoking cessation may be beneficial to RTR in delaying GF in long term.
BACKGROUND: Smoking in renal transplant recipients (RTR) is an acknowledged cardiovascular risk factor. It is, however, unclear whether smoking also increases the risk of graft failure (GF). METHOD: In this study, we prospectively assessed the association of current smoking versus past and never smoking with GF and mortality in 604 RTR (age 51.5 ± 12.1 years, 55% male). RESULTS: At inclusion, 133 (22%) were current smokers, 255 (42%) were past smokers and 216 (36%) never smoked. During follow-up of 5.3 (4.7-5.7) years, 41 (7%) RTR experienced GF and 95 RTR (16%) died. Current smoking RTR had higher risk for GF compared to never smoking RTR (hazard ratio, HR = 3.3, 95% CI 1.5-7.1, p = 0.002). Past smoking RTR had similar risk of GF as never smoking RTR (HR = 1.1, 95% CI 0.5-2.6, p = 0.7). Current smoking RTR and past smoking RTR were at higher risk for death than never smoking RTR (HR = 2.1, 95% CI 1.1-3.8, p = 0.016, and HR = 2.4, 95% CI 1.4-4.0, p = 0.001, respectively). CONCLUSION: Smoking after renal transplantation is associated with risk for GF and mortality. Since past smoking is a risk factor for mortality but not for GF, smoking cessation may be beneficial to RTR in delaying GF in long term.
Authors: Katrin Birkefeld; Maximilian Bauer-Hohmann; Felix Klewitz; Eva-Marie Kyaw Tha Tun; Uwe Tegtbur; Lars Pape; Lena Schiffer; Mario Schiffer; Martina de Zwaan; Mariel Nöhre Journal: J Clin Psychol Med Settings Date: 2022-02-23
Authors: Muhammad Abdul Mabood Khalil; Jackson Tan; Said Khamis; Muhammad AshhadUllah Khalil; Rabeea Azmat; Arslan Rahat Ullah Journal: Adv Med Date: 2017-07-27
Authors: Maryse C J Osté; António W Gomes-Neto; Eva Corpeleijn; Rijk O B Gans; Martin H de Borst; Else van den Berg; Sabita S Soedamah-Muthu; Daan Kromhout; Gerjan J Navis; Stephan J L Bakker Journal: Am J Transplant Date: 2018-03-23 Impact factor: 8.086
Authors: Regina van Zanten; Monique van Dijk; Joost van Rosmalen; Denise Beck; Robert Zietse; Ann Van Hecke; AnneLoes van Staa; Emma K Massey Journal: Trials Date: 2022-01-06 Impact factor: 2.279
Authors: Larry A Weinrauch; Brian Claggett; Jiankang Liu; Peter V Finn; Matthew R Weir; Daniel E Weiner; John A D'Elia Journal: Int J Nephrol Renovasc Dis Date: 2018-04-27
Authors: Denise Karin Beck; Mirjam Tielen; Marloes Rechards; Reinier Timman; Charlotte Boonstra; Josette Versteegh; Jacqueline van de Wetering; Robert Zietse; Teun van Gelder; Willem Weimar; Jan van Saase; Jan van Busschbach; Emma Kay Massey Journal: BMC Nephrol Date: 2020-08-28 Impact factor: 2.388